Works matching IS 13419625 AND DT 2024 AND VI 29 AND IP 6


Results: 23
    1

    Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 700, doi. 10.1007/s10147-024-02541-z
    By:
    • Tsuchihashi, Kenji;
    • Ito, Mamoru;
    • Okumura, Yuta;
    • Nio, Kenta;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro
    Publication type:
    Article
    2

    Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 764, doi. 10.1007/s10147-024-02508-0
    By:
    • Iwaki, Sho;
    • Kadowaki, Shigenori;
    • Honda, Kazunori;
    • Narita, Yukiya;
    • Masuishi, Toshiki;
    • Taniguchi, Hiroya;
    • Ando, Masashi;
    • Muro, Kei;
    • Sawabe, Michi;
    • Suzuki, Hidenori;
    • Nishikawa, Daisuke;
    • Beppu, Shintaro;
    • Terada, Hoshino;
    • Kishikawa, Toshihiro;
    • Kawakita, Daisuke;
    • Hanai, Nobuhiro
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 847, doi. 10.1007/s10147-024-02517-z
    By:
    • Nakamura, Katsumasa;
    • Nihei, Keiji;
    • Saito, Yoshihiro;
    • Shikama, Naoto;
    • Noda, Shin-ei;
    • Hara, Ryusuke;
    • Imagumbai, Toshiyuki;
    • Mizowaki, Takashi;
    • Akiba, Takeshi;
    • Kunieda, Etsuo;
    • Someya, Masanori;
    • Ohga, Saiji;
    • Kawamori, Jiro;
    • Kozuka, Takuyo;
    • Ota, Yosuke;
    • Inaba, Koji;
    • Kodaira, Takeshi;
    • Itoh, Yoshiyuki;
    • Funakoshi, Kouta;
    • Kagami, Yoshikazu
    Publication type:
    Article
    9
    10
    11
    12

    Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 681, doi. 10.1007/s10147-024-02504-4
    By:
    • Yoshinami, Tetsuhiro;
    • Nozawa, Kazuki;
    • Yokoe, Takamichi;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    13
    14

    Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 689, doi. 10.1007/s10147-024-02502-6
    By:
    • Ito, Mamoru;
    • Okumura, Yuta;
    • Nio, Kenta;
    • Baba, Eishi;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro
    Publication type:
    Article
    15

    Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 813, doi. 10.1007/s10147-024-02498-z
    By:
    • Murai, Shin;
    • Nozawa, Hiroaki;
    • Yamada, Kazutaka;
    • Saiki, Yasumitsu;
    • Sasaki, Kazuhito;
    • Murono, Koji;
    • Emoto, Shigenobu;
    • Matsuzaki, Hiroyuki;
    • Yokoyama, Yuichiro;
    • Abe, Shinya;
    • Nagai, Yuzo;
    • Yoshioka, Yuichiro;
    • Shinagawa, Takahide;
    • Sonoda, Hirofumi;
    • Sugihara, Kenichi;
    • Ajioka, Yoichi;
    • Ishihara, Soichiro
    Publication type:
    Article
    16

    Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 790, doi. 10.1007/s10147-024-02496-1
    By:
    • Kano, Yosuke;
    • Ichikawa, Hiroshi;
    • Aizawa, Masaki;
    • Muneoka, Yusuke;
    • Usui, Kenji;
    • Hanyu, Takaaki;
    • Ishikawa, Takashi;
    • Yabusaki, Hiroshi;
    • Kobayashi, Kazuaki;
    • Kuwabara, Shirou;
    • Makino, Shigeto;
    • Kawachi, Yasuyuki;
    • Miura, Kohei;
    • Tajima, Yosuke;
    • Shimada, Yoshifumi;
    • Sakata, Jun;
    • Wakai, Toshifumi
    Publication type:
    Article
    17
    18

    PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 726, doi. 10.1007/s10147-024-02494-3
    By:
    • Junior, João Neif Antonio;
    • Preto, Daniel D.'Almeida;
    • Lazarini, Maria Eduarda Zanatta Neder;
    • de Lima, Marcos Alves;
    • Bonatelli, Murilo;
    • Berardinelli, Gustavo Noriz;
    • da Silva, Vinicius Duval;
    • Pinheiro, Céline;
    • Reis, Rui Manuel;
    • Cárcano, Flavio Mavignier
    Publication type:
    Article
    19
    20

    English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 647, doi. 10.1007/s10147-024-02488-1
    By:
    • Hirota, Seiichi;
    • Tateishi, Ukihide;
    • Nakamoto, Yuji;
    • Yamamoto, Hidetaka;
    • Sakurai, Shinji;
    • Kikuchi, Hirotoshi;
    • Kanda, Tatsuo;
    • Kurokawa, Yukinori;
    • Cho, Haruhiko;
    • Nishida, Toshirou;
    • Sawaki, Akira;
    • Ozaka, Masato;
    • Komatsu, Yoshito;
    • Naito, Yoichi;
    • Honma, Yoshitaka;
    • Takahashi, Fumiaki;
    • Hashimoto, Hironobu;
    • Udo, Midori;
    • Araki, Minako;
    • Nishidate, Sumito
    Publication type:
    Article
    21

    Optimal surgical approach for mid-transverse colon cancer: a systematic review and meta-analysis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 706, doi. 10.1007/s10147-024-02486-3
    By:
    • Elkomos, Beshoy Effat;
    • Alkomos, Philopateer Effat;
    • Alkomos, Mina Fransawy;
    • Ahmed, Sameh;
    • Baqar, Safa Owhida;
    • Bhatti, Muhammad Faran Raza;
    • Junaid, Rao;
    • Hassan, Muddasir;
    • Mazhar, Muhammad;
    • Hanna, Joseph;
    • Ebeidallah, Guirgis Boushra;
    • Ali, Ayman Hossam eldin Abd el monaem
    Publication type:
    Article
    22

    Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 716, doi. 10.1007/s10147-024-02485-4
    By:
    • Matsukawa, Akihiro;
    • Rajwa, Pawel;
    • Kawada, Tatsushi;
    • Bekku, Kensuke;
    • Laukhtina, Ekaterina;
    • Klemm, Jakob;
    • Pradere, Benjamin;
    • Mori, Keiichiro;
    • Karakiewicz, Pierre I.;
    • Kimura, Takahiro;
    • Chlosta, Piotr;
    • Shariat, Shahrokh F.;
    • Yanagisawa, Takafumi
    Publication type:
    Article
    23

    MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 832, doi. 10.1007/s10147-024-02477-4
    By:
    • Nagasaka, Hirotaka;
    • Kishida, Takeshi;
    • Kouro, Taku;
    • Igarashi, Yuka;
    • Takebe, Shinichi;
    • Yamamoto, Shotaro;
    • Kondo, Takuya;
    • Koizumi, Mitsuyuki;
    • Terao, Hideyuki;
    • Suzuki, Takahisa;
    • Nakaigawa, Noboru;
    • Himuro, Hidetomo;
    • Wei, Feifei;
    • Sasada, Tetsuro
    Publication type:
    Article